Back to Search

DAVID BEARDEN, PHARM.D.

PHARM.D.

Pharmacotherapy Pharmacist

NPI: 1104050806Individual

Specialties, Licenses & Credentials

Pharmacotherapy PharmacistPrimary

Pharmacist — Pharmacotherapy

Code: 1835P1200X

0010073(OR)

Research & Publications (20)

Clinical pharmacokinetics of quinupristin/dalfopristin.
PMID 15005638·Clin Pharmacokinet·2004
6-review
Recombinant human activated protein C for use in severe sepsis.
PMID 12196063·Ann Pharmacother·2002
6-review
Mechanism of action of and resistance to quinolones.
PMID 11642689·Pharmacotherapy·2001
6-review
Telithromycin: an oral ketolide for respiratory infections.
PMID 11601667·Pharmacotherapy·2001
6-review
International NMR-based environmental metabolomics intercomparison exercise.
PMID 19209610·Environ Sci Technol·2009
4-observational
A letter to Austyn.
PMID 18788969·J Palliat Med·2008
8-other
Antimicrobial dosing considerations in obese adult patients.
PMID 17655508·Pharmacotherapy·2007
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3303 SW BOND AVE, CH12C
PORTLAND, OR 97239

Quick Facts

NPI
1104050806
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile